tiprankstipranks
Tenaya Therapeutics (TNYA)
NASDAQ:TNYA
US Market
TNYA
Tenaya Therapeutics
RESEARCH TOOLSreports
Want to see TNYA full AI Analyst Report?

Tenaya Therapeutics (TNYA) Stock News & Sentiment

3,247 Followers
Buy Rating Reiterated on Tenaya: Promising TN-401 RIDGE-1 Data, Strong Transgene Expression, and Upcoming Catalysts Support Attractive Risk/Reward
Premium
Ratings
Buy Rating Reiterated on Tenaya: Promising TN-401 RIDGE-1 Data, Strong Transgene Expression, and Upcoming Catalysts Support Attractive Risk/Reward
7d ago
TNYA
Tenaya Therapeutics: Buy Rating Reiterated on Upcoming Gene Therapy Catalysts and Unchanged $5 Price Target
Premium
Ratings
Tenaya Therapeutics: Buy Rating Reiterated on Upcoming Gene Therapy Catalysts and Unchanged $5 Price Target
17d ago
TNYA
Tenaya’s TN-401: Differentiated PKP2 Gene Therapy Opportunity Underpins Favorable Risk–Reward and Buy Rating
Premium
Ratings
Tenaya’s TN-401: Differentiated PKP2 Gene Therapy Opportunity Underpins Favorable Risk–Reward and Buy Rating
1M ago
TNYA
Advancing Pipeline and Regulatory Clarity Underpin Buy Rating on Tenaya Therapeutics
Premium
Ratings
Advancing Pipeline and Regulatory Clarity Underpin Buy Rating on Tenaya Therapeutics
2M ago
TNYA
Tenaya Therapeutics: Early Gene Therapy Promise, Cash Runway to 2H27, and 2026 Data Catalysts Support Buy Rating and $5 Target
Premium
Ratings
Tenaya Therapeutics: Early Gene Therapy Promise, Cash Runway to 2H27, and 2026 Data Catalysts Support Buy Rating and $5 Target
2M ago
TNYA
Tenaya Therapeutics: Gene Therapy Momentum and De‑Risking Clinical Milestones Support Buy Rating
Premium
Ratings
Tenaya Therapeutics: Gene Therapy Momentum and De‑Risking Clinical Milestones Support Buy Rating
2M ago
TNYA
3 Best Stocks to Buy Now, 3/10/2026, According to Top Analysts
Premium
Market News
3 Best Stocks to Buy Now, 3/10/2026, According to Top Analysts
2M ago
EVAX
IMRX
More TNYA News >

TNYA News on the Web

Canaccord Genuity Sticks to Their Buy Rating for Tenaya Therapeutics (TNYA)
TipRanks News
Neutral
Analysts Offer Insights on Healthcare Companies: ImmunityBio (IBRX) and Tenaya Therapeutics (TNYA)
TipRanks News
Neutral
Buy Rating Reiterated on Tenaya: Promising TN-401 RIDGE-1 Data, Strong Transgene Expression, and Upcoming Catalysts Support Attractive Risk/Reward
TipRanks News
Bullish
Tenaya Therapeutics Inc ata from RIDGE-1 Phase 1b/2 Clinical Trial of TN-401 in Adults with ...
GuruFocus News
Neutral
Analysts Offer Insights on Healthcare Companies: Tenaya Therapeutics (TNYA), Lineage Therap (LCTX) and RenovoRx (RNXT)
TipRanks News
Bullish
Wall Street Analysts Are Bullish on Top Healthcare Picks
TipRanks News
Bullish
Analyst Reiterates Buy on Positive TN-401 RIDGE-1 Data Despite Cutting Price Target from $19 to $3
TipRanks News
Bullish
Tenaya reports data from RIDGE-1 Phase 1b/2 clinical trial of TN-401
TipRanks News
Bullish

News Score - Last 7 Days

Not enough data to generate a sentiment score
TNYA
Sector Average
Media Buzz
This Week2 articles
Weekly Average3.25 articles
News Sentiment
Currently, no data available
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is TNYA’s Media Buzz Sentiment?
2 articles about TNYA were published this week. In an average week, 3.25 articles are published.
    What is TNYA’s weekly average amount of articles?
    In an average week, 3.25 articles about TNYA are published.
      What is TNYA’s News Sentiment?
      Currently, no data Available
      Healthcare Stocks that are Trending in the News
      GOSSGossamer Bio
      RLAYRelay Therapeutics
      ROIVRoivant Sciences
      ILAIsland Pharmaceuticals Ltd
      TLSATiziana Life Sciences
      Showing the stocks with the most bullish news sentiment over the past week